DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $8,279 | +0.1% | 33,135 | 0.0% | 0.29% | -2.7% |
Q1 2024 | $8,274 | +3.6% | 33,135 | -4.1% | 0.30% | -2.9% |
Q4 2023 | $7,989 | -6.8% | 34,535 | 0.0% | 0.31% | -16.6% |
Q3 2023 | $8,568 | +12.1% | 34,535 | +8.5% | 0.37% | +9.2% |
Q2 2023 | $7,640 | -0.1% | 31,835 | +4.9% | 0.34% | -13.0% |
Q1 2023 | $7,646 | -7.8% | 30,335 | -2.9% | 0.39% | -13.3% |
Q4 2022 | $8,290 | -99.9% | 31,235 | -5.7% | 0.44% | -4.1% |
Q3 2022 | $8,558,000 | -4.2% | 33,135 | -6.0% | 0.46% | +7.9% |
Q2 2022 | $8,933,000 | -17.8% | 35,235 | -4.9% | 0.43% | +7.2% |
Q1 2022 | $10,863,000 | -15.0% | 37,035 | -4.6% | 0.40% | -6.5% |
Q4 2021 | $12,777,000 | +1.0% | 38,835 | -6.5% | 0.43% | -2.5% |
Q3 2021 | $12,645,000 | +11.6% | 41,535 | -1.7% | 0.44% | +13.1% |
Q2 2021 | $11,334,000 | +26.4% | 42,235 | +6.0% | 0.39% | +9.3% |
Q1 2021 | $8,966,000 | +1.3% | 39,835 | 0.0% | 0.36% | -5.1% |
Q4 2020 | $8,849,000 | +1.9% | 39,835 | -1.2% | 0.38% | -8.3% |
Q3 2020 | $8,685,000 | +14.1% | 40,335 | -6.3% | 0.41% | +13.3% |
Q2 2020 | $7,610,000 | +36.6% | 43,035 | +7.0% | 0.36% | +7.1% |
Q1 2020 | $5,569,000 | -25.3% | 40,235 | -17.2% | 0.34% | +8.0% |
Q4 2019 | $7,457,000 | +6.3% | 48,585 | 0.0% | 0.31% | -1.9% |
Q3 2019 | $7,017,000 | -4.6% | 48,585 | -5.6% | 0.32% | -0.3% |
Q2 2019 | $7,358,000 | +8.5% | 51,485 | +0.2% | 0.32% | +9.6% |
Q1 2019 | $6,784,000 | +25.6% | 51,385 | -1.9% | 0.29% | +13.2% |
Q4 2018 | $5,402,000 | -9.3% | 52,385 | -4.4% | 0.26% | +13.7% |
Q3 2018 | $5,953,000 | +6.6% | 54,785 | -3.2% | 0.23% | +3.2% |
Q2 2018 | $5,584,000 | -2.3% | 56,585 | -3.1% | 0.22% | +0.9% |
Q1 2018 | $5,716,000 | +4.8% | 58,385 | -0.7% | 0.22% | +5.3% |
Q4 2017 | $5,456,000 | +12.0% | 58,785 | +3.5% | 0.21% | -11.2% |
Q3 2017 | $4,871,000 | +5.3% | 56,785 | 0.0% | 0.23% | +3.6% |
Q2 2017 | $4,627,000 | -12.6% | 56,785 | -8.2% | 0.22% | -8.9% |
Q1 2017 | $5,293,000 | +4.6% | 61,885 | -4.8% | 0.25% | +5.1% |
Q4 2016 | $5,058,000 | +6.5% | 64,985 | +7.3% | 0.23% | -1.3% |
Q3 2016 | $4,749,000 | -32.6% | 60,585 | -13.2% | 0.24% | -25.2% |
Q2 2016 | $7,048,000 | +12.6% | 69,785 | +5.8% | 0.32% | +5.7% |
Q1 2016 | $6,259,000 | -47.5% | 65,985 | -50.7% | 0.30% | +4.2% |
Q4 2015 | $11,911,000 | +101.5% | 133,970 | +93.1% | 0.29% | -0.7% |
Q3 2015 | $5,912,000 | +6.3% | 69,385 | +6.8% | 0.29% | +7.4% |
Q2 2015 | $5,560,000 | -7.7% | 64,959 | -8.5% | 0.27% | +2.3% |
Q1 2015 | $6,024,000 | -4.8% | 70,959 | -3.9% | 0.26% | -1.5% |
Q4 2014 | $6,330,000 | +3.7% | 73,859 | -8.1% | 0.27% | +8.1% |
Q3 2014 | $6,106,000 | -1.1% | 80,359 | +2.4% | 0.25% | -2.4% |
Q2 2014 | $6,177,000 | +5.0% | 78,459 | 0.0% | 0.25% | +2.4% |
Q1 2014 | $5,884,000 | – | 78,459 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |